Allyson J.  Ocean net worth and biography

Allyson Ocean Biography and Net Worth

Director of NovoCure

Allyson J. Ocean, M.D. became a director of Novocure in February 2023. Dr. Ocean is an internationally recognized academic gastrointestinal medical oncologist specializing in translational and clinical research, development of novel therapeutics and patient advocacy. 

Dr. Ocean is Professor of Clinical Medicine at Weill Cornell Medicine, where she has worked since 2004. She also currently serves as a medical oncologist and attending physician in gastrointestinal oncology at New York-Presbyterian Hospital/Weill Cornell Medical Center, as well as a medical oncologist at The Jay Monahan Center for Gastrointestinal Health. 

Dr. Ocean is co-founder and Scientific Advisory Board Chair of Let’s Win Pancreatic Cancer, an award-winning non-profit organization missioned to increase access to treatment options and clinical trials for patients with pancreatic cancer. Let’s Win received the inaugural Biden Cancer Initiative FIERCE Award for Leadership through Exemplary and Awesome Purpose for its transformative impact on the lives of cancer patients. Additionally, Dr. Ocean serves on several scientific advisory boards. Dr. Ocean is on the board of The POLG Foundation, a non-profit organization dedicated to accelerating research for treatments and a cure for POLG-related mitochondrial disorders.

Dr. Ocean graduated cum laude from Tufts University and received her M.D. with AOA honors from the Tufts University School of Medicine. She is the author of numerous peer-reviewed articles and abstracts and is an active member of several professional societies, including the American Society of Clinical Oncology, the American Association for Cancer Research, and the Stephenson Global Pancreatic Research Institute.

What is Allyson J. Ocean's net worth?

The estimated net worth of Allyson J. Ocean is at least $182.88 thousand as of June 2nd, 2026. Dr. Ocean owns 11,324 shares of NovoCure stock worth more than $182,883 as of June 4th. This net worth estimate does not reflect any other investments that Dr. Ocean may own. Learn More about Allyson J. Ocean's net worth.

How do I contact Allyson J. Ocean?

The corporate mailing address for Dr. Ocean and other NovoCure executives is NO. 4 THE FORUM GRENVILLE STREET, ST. HELIER Y9, JE2 4UF. NovoCure can also be reached via phone at 441534756700 and via email at [email protected]. Learn More on Allyson J. Ocean's contact information.

Has Allyson J. Ocean been buying or selling shares of NovoCure?

Within the last three months, Allyson J. Ocean has sold $46,442.65 of NovoCure stock. Most recently, Allyson J. Ocean sold 2,945 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $15.77, for a transaction totalling $46,442.65. Following the completion of the sale, the director now directly owns 11,324 shares of the company's stock, valued at $178,579.48. Learn More on Allyson J. Ocean's trading history.

Who are NovoCure's active insiders?

NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Christoph Brackmann (CFO), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Executive Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Allyson Ocean (Director), Mukund Paravasthu (COO), Michael Puri (Insider), Pritesh Shah (Insider), William Vernon (Director), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.

Are insiders buying or selling shares of NovoCure?

During the last twelve months, NovoCure insiders bought shares 2 times. They purchased a total of 101,550 shares worth more than $1,228,341.00. During the last twelve months, insiders at the medical equipment provider sold shares 13 times. They sold a total of 157,711 shares worth more than $2,138,772.06. The most recent insider tranaction occured on June, 2nd when Director Gabriel Leung sold 2,945 shares worth more than $46,442.65. Insiders at NovoCure own 5.5% of the company. Learn More about insider trades at NovoCure.

Information on this page was last updated on 6/2/2026.

Allyson J. Ocean Insider Trading History at NovoCure

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/2/2026Sell2,945$15.77$46,442.6511,324View SEC Filing Icon  
See Full Table

Allyson J. Ocean Buying and Selling Activity at NovoCure

This chart shows Allyson J Ocean's buying and selling at NovoCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NovoCure Company Overview

NovoCure logo
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Read More

Today's Range

Now: $17.99
Low: $16.23
High: $18.39

50 Day Range

MA: $14.16
Low: $10.35
High: $18.31

2 Week Range

Now: $17.99
Low: $9.82
High: $19.25

Volume

744,855 shs

Average Volume

1,764,437 shs

Market Capitalization

$2.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93